Wegovy, Zepbound, Foundayo, and Saxenda medication are all FDA approved for weight loss in certain patients, but contain different active ingredients
Evidence and UK Guidance GLP-1 receptor agonists have gained considerable attention for their role in weight management, prompting questions about their effects on abdominal fat
Some research suggests that people dont like sweet and high-fat foods as much when they are taking GLP-1 drugs
If keto can shift that ratio, preserving muscle while still producing significant fat loss, the combination addresses the single biggest criticism of GLP-1 therapy for body composition
Drugs@FDA: Approval updates for GLP-1 receptor agonists for diabetes and chronic weight management
This is fundamentally different from oral medications, which spike in the bloodstream shortly after absorption and then decline